Aurora Financial Journal

Nanologica AB (publ) (NICA.ST)

Nasdaq Stockholm · Financial statements, TTM figures and earnings dates

In fiscal year 2024 (ended December 31, 2024), Nanologica AB (publ) reported revenue of SEK 14.5M and net income of −SEK 65.6M. Annual financial statements are available for fiscal years 2022 to 2024, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

SEKFY2024
2024-12-31
FY2023
2023-12-31
FY2022
2022-12-31
Income statement
RevenueSEK 14.5MSEK 1.4MSEK 1.6M
Operating income−SEK 59.3M−SEK 70.0M−SEK 50.9M
Net income−SEK 65.6M−SEK 75.2M−SEK 55.2M
Diluted EPS−SEK 1.32−SEK 2.08−SEK 1.84
Cash flow
Operating cash flow−SEK 80.7M−SEK 35.8M−SEK 45.2M
Capital expenditureSEK 262.0KSEK 1.8MSEK 1.6M
Free cash flow−SEK 81.0M−SEK 37.6M−SEK 46.8M
Balance sheet
Cash and equivalentsSEK 48.4MSEK 10.1MSEK 70.3M
Total assetsSEK 143.1MSEK 77.4MSEK 154.5M
Total liabilitiesSEK 69.0MSEK 79.3MSEK 81.4M
Total debtSEK 24.0KSEK 66.8MSEK 66.6M
Shareholders' equitySEK 74.1M−SEK 1.9MSEK 73.2M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in SEK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full NICA.ST page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open NICA.ST financials →